Search, analyze & compare

My selected companies

Adjust valuation method
WatchlistNameTickerP/EP/SP/BEV/EbitdaROEROICRSISMA200DCFVolumeClosing price
-
Exscientia plcEXAI-4.5129.332.08-2.76-36.34%-13.17%37.83$5.05$17.737,112$4.87

Detail of Exscientia plc

 
CEO
Dr. David Hallett Ph.D.
Employees
483
Industry
Biotechnology
Sector
Healthcare
Market cap
$617M

Company details

Exscientia plc, an artificial intelligence (AI) driven Pharma-tech company, engages in design and develop differentiated medicines for diseases with high unmet patient needs. The company's lead product candidate GTAEXS617, a CDK7 inhibitor, which is currently in a Phase 1/2 trial to manage the potential toxicities associated with CDK7 as well as optimizing pharmacokinetics for maximizing on-target efficacy. It is also involved in the development of EXS4318, a PKC-theta inhibitor, under Phase 1 clinical trial for inflammation and immunology indications; EXS74539, a LSD1 inhibitor, under preclinical studies for SCLC, AML, and potential additional indications; EXS73565, a MALT1 inhibitor, under preclinical studies for multiple hematology indications; and DSP-0038, currently in Phase 1 studies. The company has collaboration agreements with Merck KGaA, Bristol Myers Squibb, Sanofi, Bill & Melinda Gates Foundation, Charité – Universitätsmedizin Berlin, Rallybio, and GT Apeiron Therapeutics. Exscientia plc was founded in 2012 and is headquartered in Oxford, the United Kingdom.

Revenue
Cost of goods
Gross profit
OE
R&D
G&A
OTH
OI
OIE
PI
TAX
NI
Revenue (Rev)
$21.02M
Cost of goods (CoG)
-$27.84M
Gross profit (GP)
-$6.82M
Operating expense (OE)
-$144.31M
Research and development (R&D)
-$109.81M
General and administrative (G&A)
-$43.02M
Other (OTH)
$8.52M
Operating income (OI)
-$151.13M
Other income expense (OIE)
-$925,000.00
Pretax income (PI)
-$136.60M
Tax (TAX)
$7.00M
Net income (NI)
-$129.60M
Exscientia plc
EXAI • XNGS • US
$4.87
-0.64 (-11.64%)
Stock vs Industry average
  • Industry average

Negative values are hidden from the graph.
Trailing annual dividend rate
$0.00
Payout ratio
0.00%
EPS
-$1.08
Margin profit
-36.48%
52 week low
$3.99
52 week high
$7.51
50-day simple moving average
$5.02
200-day simple moving average
$5.05
Percent held by insiders
25.90%
Percent held by institutions
22.08%
Dividend yield
0.00%

Change of shares

Cash vs Debt

Comparison of selected companies

 
%
Price change
EXAI -16.35%
eps change
EXAI 0.00%